HEADER TRANSCRIPTION 25-MAY-19 5QSN TITLE PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF HUMAN STAG1 TITLE 2 IN COMPLEX WITH Z1272480091 COMPND MOL_ID: 1; COMPND 2 MOLECULE: COHESIN SUBUNIT SA-1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: SCC3 HOMOLOG 1,STROMAL ANTIGEN 1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: STAG1, SA1, SCC3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SGC - DIAMOND I04-1 FRAGMENT SCREENING, PANDDA, XCHEMEXPLORER, KEYWDS 2 TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR J.A.NEWMAN,V.L.KATIS,A.E.GAVARD,F.VON DELFT,C.H.ARROWSMITH,A.EDWARDS, AUTHOR 2 C.BOUNTRA,O.GILEADI REVDAT 2 06-MAR-24 5QSN 1 REMARK REVDAT 1 21-AUG-19 5QSN 0 JRNL AUTH J.A.NEWMAN,V.L.KATIS,A.E.GAVARD,F.VON DELFT,C.H.ARROWSMITH, JRNL AUTH 2 A.EDWARDS,C.BOUNTRA,O.GILEADI JRNL TITL PANDDA ANALYSIS GROUP DEPOSITION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.66 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0238 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.66 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 113.82 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 34533 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.221 REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.288 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1832 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.66 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.73 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2440 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.98 REMARK 3 BIN R VALUE (WORKING SET) : 0.4050 REMARK 3 BIN FREE R VALUE SET COUNT : 125 REMARK 3 BIN FREE R VALUE : 0.4460 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6922 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 15 REMARK 3 SOLVENT ATOMS : 154 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 75.09 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.66000 REMARK 3 B22 (A**2) : 0.67000 REMARK 3 B33 (A**2) : 4.99000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.631 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.353 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.392 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 21.796 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.954 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.931 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 7059 ; 0.006 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 6626 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 9534 ; 1.453 ; 1.630 REMARK 3 BOND ANGLES OTHERS (DEGREES): 15397 ; 1.234 ; 1.574 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 850 ; 6.946 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 367 ;38.673 ;23.733 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1311 ;18.509 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 32 ;15.994 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 929 ; 0.067 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 7711 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1388 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3430 ; 5.921 ; 7.904 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 3429 ; 5.918 ; 7.903 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4270 ; 9.114 ;11.827 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 5QSN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-JUN-19. REMARK 100 THE DEPOSITION ID IS D_1001402356. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-APR-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91587 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.6.2 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36436 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.660 REMARK 200 RESOLUTION RANGE LOW (A) : 113.820 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : 0.13000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.66 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.73 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.10 REMARK 200 R MERGE FOR SHELL (I) : 0.86000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: 6R7O REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M BIS TRIS PROPANE PH 7.0, 0.2 M REMARK 280 SODIUM MALONATE, 20 % PEG 3350, 10 % ETHYLENE GLYCOL, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 77.49200 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 83.84400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 77.49200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 83.84400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1111 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 457 REMARK 465 GLN A 512 REMARK 465 GLY A 513 REMARK 465 GLY A 548 REMARK 465 LYS A 549 REMARK 465 GLY A 680 REMARK 465 GLU A 681 REMARK 465 ASP A 842 REMARK 465 GLU A 843 REMARK 465 GLU A 844 REMARK 465 ASN A 845 REMARK 465 GLN A 846 REMARK 465 SER A 847 REMARK 465 MET A 848 REMARK 465 GLU A 849 REMARK 465 GLY A 850 REMARK 465 ASP A 851 REMARK 465 GLU A 852 REMARK 465 GLU A 853 REMARK 465 ASP A 854 REMARK 465 ARG A 912 REMARK 465 GLN A 913 REMARK 465 ILE A 914 REMARK 465 ASP A 915 REMARK 465 SER B 457 REMARK 465 MET B 458 REMARK 465 SER B 459 REMARK 465 PRO B 510 REMARK 465 VAL B 511 REMARK 465 GLN B 512 REMARK 465 GLY B 513 REMARK 465 GLU B 514 REMARK 465 GLU B 515 REMARK 465 THR B 547 REMARK 465 GLY B 548 REMARK 465 LYS B 549 REMARK 465 ARG B 550 REMARK 465 GLY B 680 REMARK 465 GLU B 681 REMARK 465 GLU B 682 REMARK 465 ALA B 683 REMARK 465 GLN B 841 REMARK 465 ASP B 842 REMARK 465 GLU B 843 REMARK 465 GLU B 844 REMARK 465 ASN B 845 REMARK 465 GLN B 846 REMARK 465 SER B 847 REMARK 465 MET B 848 REMARK 465 GLU B 849 REMARK 465 GLY B 850 REMARK 465 ASP B 851 REMARK 465 GLU B 852 REMARK 465 GLU B 853 REMARK 465 ARG B 912 REMARK 465 GLN B 913 REMARK 465 ILE B 914 REMARK 465 ASP B 915 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A 458 CG SD CE REMARK 470 GLU A 476 CG CD OE1 OE2 REMARK 470 GLU A 514 CG CD OE1 OE2 REMARK 470 ARG A 550 CG CD NE CZ NH1 NH2 REMARK 470 THR B 649 OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LEU A 829 O HOH A 1001 2.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 492 29.00 -140.63 REMARK 500 GLU A 515 103.53 94.73 REMARK 500 CYS A 644 -99.49 -59.30 REMARK 500 SER A 645 30.44 -77.14 REMARK 500 GLU A 647 112.03 153.05 REMARK 500 GLU A 725 -70.71 -59.90 REMARK 500 ARG A 811 47.58 -93.00 REMARK 500 ALA A 856 -39.99 -36.93 REMARK 500 SER B 518 174.59 -56.92 REMARK 500 ASP B 519 -72.23 -66.50 REMARK 500 ARG B 520 -26.41 -39.02 REMARK 500 ARG B 534 -70.91 -50.57 REMARK 500 VAL B 543 109.58 -44.23 REMARK 500 ARG B 545 4.46 -159.46 REMARK 500 ALA B 554 -12.94 69.78 REMARK 500 ILE B 603 -4.68 -47.86 REMARK 500 ARG B 608 71.51 37.30 REMARK 500 GLU B 646 11.95 86.68 REMARK 500 GLU B 647 -69.74 -101.30 REMARK 500 THR B 649 -14.52 -43.90 REMARK 500 GLN B 678 -66.92 -153.00 REMARK 500 ASP B 706 109.61 -55.68 REMARK 500 HIS B 726 -63.94 -139.01 REMARK 500 ARG B 811 57.32 -115.58 REMARK 500 GLU B 860 -76.19 -43.09 REMARK 500 HIS B 892 69.36 -116.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PHE B 599 ASP B 600 148.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue O2J B 1001 DBREF 5QSN A 459 915 UNP Q8WVM7 STAG1_HUMAN 459 915 DBREF 5QSN B 459 915 UNP Q8WVM7 STAG1_HUMAN 459 915 SEQADV 5QSN SER A 457 UNP Q8WVM7 EXPRESSION TAG SEQADV 5QSN MET A 458 UNP Q8WVM7 EXPRESSION TAG SEQADV 5QSN SER B 457 UNP Q8WVM7 EXPRESSION TAG SEQADV 5QSN MET B 458 UNP Q8WVM7 EXPRESSION TAG SEQRES 1 A 459 SER MET SER PRO ASN GLY ASN LEU ILE ARG MET LEU VAL SEQRES 2 A 459 LEU PHE PHE LEU GLU SER GLU LEU HIS GLU HIS ALA ALA SEQRES 3 A 459 TYR LEU VAL ASP SER LEU TRP GLU SER SER GLN GLU LEU SEQRES 4 A 459 LEU LYS ASP TRP GLU CYS MET THR GLU LEU LEU LEU GLU SEQRES 5 A 459 GLU PRO VAL GLN GLY GLU GLU ALA MET SER ASP ARG GLN SEQRES 6 A 459 GLU SER ALA LEU ILE GLU LEU MET VAL CYS THR ILE ARG SEQRES 7 A 459 GLN ALA ALA GLU ALA HIS PRO PRO VAL GLY ARG GLY THR SEQRES 8 A 459 GLY LYS ARG VAL LEU THR ALA LYS GLU ARG LYS THR GLN SEQRES 9 A 459 ILE ASP ASP ARG ASN LYS LEU THR GLU HIS PHE ILE ILE SEQRES 10 A 459 THR LEU PRO MET LEU LEU SER LYS TYR SER ALA ASP ALA SEQRES 11 A 459 GLU LYS VAL ALA ASN LEU LEU GLN ILE PRO GLN TYR PHE SEQRES 12 A 459 ASP LEU GLU ILE TYR SER THR GLY ARG MET GLU LYS HIS SEQRES 13 A 459 LEU ASP ALA LEU LEU LYS GLN ILE LYS PHE VAL VAL GLU SEQRES 14 A 459 LYS HIS VAL GLU SER ASP VAL LEU GLU ALA CYS SER LYS SEQRES 15 A 459 THR TYR SER ILE LEU CYS SER GLU GLU TYR THR ILE GLN SEQRES 16 A 459 ASN ARG VAL ASP ILE ALA ARG SER GLN LEU ILE ASP GLU SEQRES 17 A 459 PHE VAL ASP ARG PHE ASN HIS SER VAL GLU ASP LEU LEU SEQRES 18 A 459 GLN GLU GLY GLU GLU ALA ASP ASP ASP ASP ILE TYR ASN SEQRES 19 A 459 VAL LEU SER THR LEU LYS ARG LEU THR SER PHE HIS ASN SEQRES 20 A 459 ALA HIS ASP LEU THR LYS TRP ASP LEU PHE GLY ASN CYS SEQRES 21 A 459 TYR ARG LEU LEU LYS THR GLY ILE GLU HIS GLY ALA MET SEQRES 22 A 459 PRO GLU GLN ILE VAL VAL GLN ALA LEU GLN CYS SER HIS SEQRES 23 A 459 TYR SER ILE LEU TRP GLN LEU VAL LYS ILE THR ASP GLY SEQRES 24 A 459 SER PRO SER LYS GLU ASP LEU LEU VAL LEU ARG LYS THR SEQRES 25 A 459 VAL LYS SER PHE LEU ALA VAL CYS GLN GLN CYS LEU SER SEQRES 26 A 459 ASN VAL ASN THR PRO VAL LYS GLU GLN ALA PHE MET LEU SEQRES 27 A 459 LEU CYS ASP LEU LEU MET ILE PHE SER HIS GLN LEU MET SEQRES 28 A 459 THR GLY GLY ARG GLU GLY LEU GLN PRO LEU VAL PHE ASN SEQRES 29 A 459 PRO ASP THR GLY LEU GLN SER GLU LEU LEU SER PHE VAL SEQRES 30 A 459 MET ASP HIS VAL PHE ILE ASP GLN ASP GLU GLU ASN GLN SEQRES 31 A 459 SER MET GLU GLY ASP GLU GLU ASP GLU ALA ASN LYS ILE SEQRES 32 A 459 GLU ALA LEU HIS LYS ARG ARG ASN LEU LEU ALA ALA PHE SEQRES 33 A 459 SER LYS LEU ILE ILE TYR ASP ILE VAL ASP MET HIS ALA SEQRES 34 A 459 ALA ALA ASP ILE PHE LYS HIS TYR MET LYS TYR TYR ASN SEQRES 35 A 459 ASP TYR GLY ASP ILE ILE LYS GLU THR LEU SER LYS THR SEQRES 36 A 459 ARG GLN ILE ASP SEQRES 1 B 459 SER MET SER PRO ASN GLY ASN LEU ILE ARG MET LEU VAL SEQRES 2 B 459 LEU PHE PHE LEU GLU SER GLU LEU HIS GLU HIS ALA ALA SEQRES 3 B 459 TYR LEU VAL ASP SER LEU TRP GLU SER SER GLN GLU LEU SEQRES 4 B 459 LEU LYS ASP TRP GLU CYS MET THR GLU LEU LEU LEU GLU SEQRES 5 B 459 GLU PRO VAL GLN GLY GLU GLU ALA MET SER ASP ARG GLN SEQRES 6 B 459 GLU SER ALA LEU ILE GLU LEU MET VAL CYS THR ILE ARG SEQRES 7 B 459 GLN ALA ALA GLU ALA HIS PRO PRO VAL GLY ARG GLY THR SEQRES 8 B 459 GLY LYS ARG VAL LEU THR ALA LYS GLU ARG LYS THR GLN SEQRES 9 B 459 ILE ASP ASP ARG ASN LYS LEU THR GLU HIS PHE ILE ILE SEQRES 10 B 459 THR LEU PRO MET LEU LEU SER LYS TYR SER ALA ASP ALA SEQRES 11 B 459 GLU LYS VAL ALA ASN LEU LEU GLN ILE PRO GLN TYR PHE SEQRES 12 B 459 ASP LEU GLU ILE TYR SER THR GLY ARG MET GLU LYS HIS SEQRES 13 B 459 LEU ASP ALA LEU LEU LYS GLN ILE LYS PHE VAL VAL GLU SEQRES 14 B 459 LYS HIS VAL GLU SER ASP VAL LEU GLU ALA CYS SER LYS SEQRES 15 B 459 THR TYR SER ILE LEU CYS SER GLU GLU TYR THR ILE GLN SEQRES 16 B 459 ASN ARG VAL ASP ILE ALA ARG SER GLN LEU ILE ASP GLU SEQRES 17 B 459 PHE VAL ASP ARG PHE ASN HIS SER VAL GLU ASP LEU LEU SEQRES 18 B 459 GLN GLU GLY GLU GLU ALA ASP ASP ASP ASP ILE TYR ASN SEQRES 19 B 459 VAL LEU SER THR LEU LYS ARG LEU THR SER PHE HIS ASN SEQRES 20 B 459 ALA HIS ASP LEU THR LYS TRP ASP LEU PHE GLY ASN CYS SEQRES 21 B 459 TYR ARG LEU LEU LYS THR GLY ILE GLU HIS GLY ALA MET SEQRES 22 B 459 PRO GLU GLN ILE VAL VAL GLN ALA LEU GLN CYS SER HIS SEQRES 23 B 459 TYR SER ILE LEU TRP GLN LEU VAL LYS ILE THR ASP GLY SEQRES 24 B 459 SER PRO SER LYS GLU ASP LEU LEU VAL LEU ARG LYS THR SEQRES 25 B 459 VAL LYS SER PHE LEU ALA VAL CYS GLN GLN CYS LEU SER SEQRES 26 B 459 ASN VAL ASN THR PRO VAL LYS GLU GLN ALA PHE MET LEU SEQRES 27 B 459 LEU CYS ASP LEU LEU MET ILE PHE SER HIS GLN LEU MET SEQRES 28 B 459 THR GLY GLY ARG GLU GLY LEU GLN PRO LEU VAL PHE ASN SEQRES 29 B 459 PRO ASP THR GLY LEU GLN SER GLU LEU LEU SER PHE VAL SEQRES 30 B 459 MET ASP HIS VAL PHE ILE ASP GLN ASP GLU GLU ASN GLN SEQRES 31 B 459 SER MET GLU GLY ASP GLU GLU ASP GLU ALA ASN LYS ILE SEQRES 32 B 459 GLU ALA LEU HIS LYS ARG ARG ASN LEU LEU ALA ALA PHE SEQRES 33 B 459 SER LYS LEU ILE ILE TYR ASP ILE VAL ASP MET HIS ALA SEQRES 34 B 459 ALA ALA ASP ILE PHE LYS HIS TYR MET LYS TYR TYR ASN SEQRES 35 B 459 ASP TYR GLY ASP ILE ILE LYS GLU THR LEU SER LYS THR SEQRES 36 B 459 ARG GLN ILE ASP HET O2J B1001 15 HETNAM O2J (2R)-2-(METHOXYMETHYL)-4-(PYRIDIN-2-YL)MORPHOLINE FORMUL 3 O2J C11 H16 N2 O2 FORMUL 4 HOH *154(H2 O) HELIX 1 AA1 SER A 459 SER A 475 1 17 HELIX 2 AA2 HIS A 480 LYS A 497 1 18 HELIX 3 AA3 ASP A 498 GLU A 508 1 11 HELIX 4 AA4 SER A 518 ALA A 539 1 22 HELIX 5 AA5 THR A 553 SER A 583 1 31 HELIX 6 AA6 ASP A 585 LEU A 593 1 9 HELIX 7 AA7 GLN A 594 PHE A 599 5 6 HELIX 8 AA8 ASP A 600 LEU A 601 5 2 HELIX 9 AA9 GLU A 602 GLY A 607 1 6 HELIX 10 AB1 MET A 609 HIS A 627 1 19 HELIX 11 AB2 GLU A 629 SER A 645 1 17 HELIX 12 AB3 GLU A 647 GLU A 679 1 33 HELIX 13 AB4 ASP A 684 ASN A 703 1 20 HELIX 14 AB5 ASP A 711 HIS A 726 1 16 HELIX 15 AB6 PRO A 730 GLY A 755 1 26 HELIX 16 AB7 SER A 758 LEU A 780 1 23 HELIX 17 AB8 ASN A 784 PHE A 802 1 19 HELIX 18 AB9 SER A 803 THR A 808 5 6 HELIX 19 AC1 ARG A 811 VAL A 818 5 8 HELIX 20 AC2 ASP A 822 VAL A 837 1 16 HELIX 21 AC3 ALA A 856 TYR A 878 1 23 HELIX 22 AC4 ASP A 882 LYS A 910 1 29 HELIX 23 AC5 ASN B 461 SER B 475 1 15 HELIX 24 AC6 HIS B 480 LEU B 488 1 9 HELIX 25 AC7 LEU B 488 LYS B 497 1 10 HELIX 26 AC8 ASP B 498 GLU B 508 1 11 HELIX 27 AC9 SER B 518 ALA B 539 1 22 HELIX 28 AD1 LYS B 555 TYR B 582 1 28 HELIX 29 AD2 ASP B 585 LEU B 593 1 9 HELIX 30 AD3 GLN B 594 PHE B 599 5 6 HELIX 31 AD4 ASP B 600 SER B 605 5 6 HELIX 32 AD5 MET B 609 HIS B 627 1 19 HELIX 33 AD6 GLU B 629 CYS B 644 1 16 HELIX 34 AD7 ILE B 650 LEU B 677 1 28 HELIX 35 AD8 ASP B 685 ASN B 703 1 19 HELIX 36 AD9 ASP B 711 GLU B 725 1 15 HELIX 37 AE1 PRO B 730 GLY B 755 1 26 HELIX 38 AE2 SER B 758 LEU B 780 1 23 HELIX 39 AE3 ASN B 784 PHE B 802 1 19 HELIX 40 AE4 SER B 803 MET B 807 5 5 HELIX 41 AE5 ARG B 811 VAL B 818 5 8 HELIX 42 AE6 ASP B 822 VAL B 837 1 16 HELIX 43 AE7 ASN B 857 TYR B 878 1 22 HELIX 44 AE8 ASP B 882 ALA B 887 1 6 HELIX 45 AE9 ILE B 889 TYR B 893 5 5 HELIX 46 AF1 TYR B 900 THR B 911 1 12 SITE 1 AC1 6 LEU B 862 HIS B 863 ARG B 866 TYR B 897 SITE 2 AC1 6 ASN B 898 ASP B 902 CRYST1 154.984 167.688 47.106 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006452 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005963 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021229 0.00000